STOCK TITAN

Xtra Gold Res Financials

XTGRF
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Xtra Gold Res (XTGRF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 23 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 41 / 100
Financial Profile 41/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Xtra Gold Res's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage
100

Xtra Gold Res carries a low D/E ratio of 0.09, meaning only $0.09 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
100

With a current ratio of 10.96, Xtra Gold Res holds $10.96 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Returns
45

Xtra Gold Res's ROE of 22.7% shows moderate profitability relative to equity, earning a score of 45/100. This is up from 14.1% the prior year.

Piotroski F-Score Neutral
4/9

Xtra Gold Res passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality
0.31x

For every $1 of reported earnings, Xtra Gold Res generates $0.31 in operating cash flow ($1.1M OCF vs $3.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
-$2.2M
YoY-44.2%

Xtra Gold Res's EBITDA was -$2.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 44.2% from the prior year.

Net Income
$3.7M
YoY+119.9%
5Y CAGR+14.6%

Xtra Gold Res reported $3.7M in net income in fiscal year 2025. This represents an increase of 119.9% from the prior year.

EPS (Diluted)
$0.08
YoY+166.7%
5Y CAGR+14.9%

Xtra Gold Res earned $0.08 per diluted share (EPS) in fiscal year 2025. This represents an increase of 166.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$902K
YoY-59.7%
5Y CAGR+37.2%
10Y CAGR+40.2%

Xtra Gold Res generated $902K in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 59.7% from the prior year.

Cash & Debt
$10.5M
YoY+28.4%
5Y CAGR+18.7%
10Y CAGR+25.5%

Xtra Gold Res held $10.5M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
47M
YoY+1.5%
5Y CAGR-0.1%
10Y CAGR+0.2%

Xtra Gold Res had 47M shares outstanding in fiscal year 2025. This represents an increase of 1.5% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
22.7%
YoY+8.5pp
5Y CAGR+2.5pp
10Y CAGR+43.0pp

Xtra Gold Res's ROE was 22.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 8.5 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$625K
YoY+261.4%
5Y CAGR+38.7%
10Y CAGR+41.9%

Xtra Gold Res spent $625K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 261.4% from the prior year.

Capital Expenditures
$248K
YoY+506.4%
5Y CAGR-5.0%

Xtra Gold Res invested $248K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 506.4% from the prior year.

XTGRF Income Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

XTGRF Balance Sheet

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Total Assets $18.5M+29.9% $14.2M+19.9% $11.9M-0.2% $11.9M+10.4% $10.8M+15.2% $9.3M+35.9% $6.9M+43.5% $4.8M
Current Assets $16.9M+32.5% $12.7M+23.9% $10.3M+1.1% $10.2M+11.5% $9.1M+17.9% $7.7M+42.3% $5.4M+66.9% $3.3M
Cash & Equivalents $10.5M+28.4% $8.2M+14.3% $7.2M+23.8% $5.8M+23.6% $4.7M+5.0% $4.5M+11.8% $4.0M+55.3% $2.6M
Inventory $1.8M+56.6% $1.2M+42.0% $818K+2.7% $796K-18.4% $975K+15.8% $842K+114.2% $393K+160.4% $151K
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $1.5M-22.6% $2.0M+31.1% $1.5M+8.0% $1.4M+25.3% $1.1M+163.0% $427K-3.8% $444K-28.9% $624K
Current Liabilities $1.5M-22.6% $2.0M+31.1% $1.5M+8.0% $1.4M+25.3% $1.1M+163.0% $427K-3.8% $444K-28.9% $624K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $16.3M+37.1% $11.9M+16.1% $10.2M-3.0% $10.5M+7.2% $9.8M+6.5% $9.2M+34.0% $6.9M+44.6% $4.8M
Retained Earnings -$16.2M+18.6% -$19.8M+7.8% -$21.5M-0.8% -$21.3M+2.9% -$22.0M+3.7% -$22.8M+7.5% -$24.7M+8.4% -$26.9M

XTGRF Cash Flow Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Operating Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

XTGRF Financial Ratios

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 10.96+4.6 6.40-0.4 6.77-0.5 7.24-0.9 8.13-10.0 18.13+5.9 12.26+7.0 5.22
Debt-to-Equity 0.09-0.1 0.17+0.0 0.15+0.0 0.13+0.0 0.11+0.1 0.05-0.0 0.06-0.1 0.13
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Yes, Xtra Gold Res (XTGRF) reported a net income of $3.7M in fiscal year 2025.

Xtra Gold Res (XTGRF) reported diluted earnings per share of $0.08 for fiscal year 2025. This represents a 166.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Xtra Gold Res (XTGRF) had EBITDA of -$2.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Xtra Gold Res (XTGRF) has a return on equity of 22.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Xtra Gold Res (XTGRF) generated $902K in free cash flow during fiscal year 2025. This represents a -59.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Xtra Gold Res (XTGRF) generated $1.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Xtra Gold Res (XTGRF) had $18.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Xtra Gold Res (XTGRF) invested $248K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Xtra Gold Res (XTGRF) spent $625K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Xtra Gold Res (XTGRF) had 47M shares outstanding as of fiscal year 2025.

Xtra Gold Res (XTGRF) had a current ratio of 10.96 as of fiscal year 2025, which is generally considered healthy.

Xtra Gold Res (XTGRF) had a debt-to-equity ratio of 0.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Xtra Gold Res (XTGRF) had a return on assets of 19.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Xtra Gold Res (XTGRF) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Xtra Gold Res (XTGRF) has an earnings quality ratio of 0.31x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Xtra Gold Res (XTGRF) scores 41 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top